(19)
(11) EP 4 045 134 A1

(12)

(43) Date of publication:
24.08.2022 Bulletin 2022/34

(21) Application number: 20728306.0

(22) Date of filing: 04.05.2020
(51) International Patent Classification (IPC): 
A61N 1/05(2006.01)
A61N 1/36(2006.01)
A61N 1/378(2006.01)
A61N 1/372(2006.01)
A61N 1/375(2006.01)
(52) Cooperative Patent Classification (CPC):
A61N 1/0548; A61N 1/3611; A61N 1/375; A61N 1/37229; A61N 1/3787; A61N 1/3601; A61N 1/0551; A61N 1/0558
(86) International application number:
PCT/US2020/031279
(87) International publication number:
WO 2021/076188 (22.04.2021 Gazette 2021/16)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 15.10.2019 US 201962915194 P

(71) Applicant: XII Medical, Inc.
Cleveland, Ohio 44195 (US)

(72) Inventors:
  • CAPARSO, Anthony V.
    Ridgeville, Ohio 44039 (US)
  • NICKOLS, Josh
    Louisville, Kentucky 40205 (US)

(74) Representative: Forresters IP LLP 
Skygarden Erika-Mann-Straße 11
80636 München
80636 München (DE)

   


(54) BIASED NEUROMODULATION LEAD AND METHOD OF USING SAME